Developing a modified low-density lipoprotein (M-LDL-C) Friedewald’s equation as a substitute for direct LDL-C measure in a Ghanaian population: a comparative study by Ephraim, Richard K. et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
1-1-2018 
Developing a modified low-density lipoprotein (M-LDL-C) 
Friedewald’s equation as a substitute for direct LDL-C measure in 
a Ghanaian population: a comparative study 
Richard K. Ephraim 
Emmanuel Acheampong 
Edith Cowan University 
Swithin M. Swaray 
Enoch Odame Anto 
Edith Cowan University 
Hope Agbodzakey 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Medicine and Health Sciences Commons 
10.1155/2018/7078409 
Ephraim, R. K., Acheampong, E., Swaray, S. M., Odame Anto, E., Agbodzakey, H., Adoba, P., ... & Amoah, B. (2018). 
Developing a modified low-density lipoprotein (M-LDL-C) Friedewald’s equation as a substitute for direct LDL-C 
measure in a Ghanaian population: a comparative study. Journal of Lipids, 2018. https://doi.org/10.1155/2018/
7078409 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/11187 
Authors 
Richard K. Ephraim, Emmanuel Acheampong, Swithin M. Swaray, Enoch Odame Anto, Hope Agbodzakey, 
Prince Adoba, Bright Oppong Afranie, Emmanuella Nsenbah Batu, Patrick Adu, Linda Ahenkorah Fondjo, 
Samuel Asamoah Sakyi, and Beatrice Amoah 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/11187 
Research Article
Developing a Modified Low-Density Lipoprotein (M-LDL-C)
Friedewald’s Equation as a Substitute for Direct LDL-C Measure
in a Ghanaian Population: A Comparative Study
Richard K. D. Ephraim ,1 Emmanuel Acheampong ,2,3 Swithin M. Swaray,1
Enoch Odame Anto ,2,3 Hope Agbodzakey,2 Prince Adoba ,2 Bright Oppong Afranie,2
Emmanuella Nsenbah Batu,2,4 Patrick Adu ,1 Linda Ahenkorah Fondjo ,2
Samuel Asamoah Sakyi ,2 and Beatrice Amoah2
1Department of Medical Laboratory Science, School of Allied Health Sciences, University of Cape Coast, Ghana
2Department of Molecular Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Ghana
3School of Medical and Health Sciences, Edith Cowan University, Western Australia, Australia
4Department of Biochemistry, Dalian Medical University, China
Correspondence should be addressed to Emmanuel Acheampong; emmanuelachea1990@yahoo.com
Received 21 September 2018; Revised 24 November 2018; Accepted 20 December 2018; Published 31 December 2018
Academic Editor: Gerhard M. Kostner
Copyright © 2018 Richard K. D. Ephraim et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Despite the availability of several homogenous LDL-C assays, calculated Friedewald’s LDL-C equation remains the widely used
formula in clinical practice. Several novel formulas developed in different populations have been reported to outperform the
Friedewald formula.This study validated the existing LDL-C formulas andderived amodifiedLDL-C formula specific to aGhanaian
population. In this comparative study, we recruited 1518 participants, derived a new modified Friedewald’s LDL-C (M-LDL-C)
equation, evaluated LDL-C by Friedewald’s formula (F-LDL-C), Martin’s formula (N-LDL-C), Anandaraja’s formula (A-LDL-C),
and compared them to direct measurement of LDL-C (D-LDL-C). The mean D-LDL-C (2.47±0.71 mmol/L) was significantly
lower compared to F-LDL-C (2.76±1.05 mmol/L), N-LDL-C (2.74±1.04 mmol/L), A-LDL-C (2.99±1.02 mmol/L), and M-LDL-C
(2.97±1.08 mmol/L) p < 0.001. There was a significantly positive correlation between D-LDL-C and A-LDL-C (r=0.658, p<0.0001),
N-LDL-C (r=0.693, p<0.0001), andM-LDL-C (r=0.693, p<0.0001). M-LDL-c yielded a better diagnostic performance [(area under
the curve (AUC)=0.81; sensitivity (SE) (60%) and specificity (SP) (88%)] followed by N-LDL-C [(AUC=0.81; SE (63%) and SP
(85%)], F-LDL-C [(AUC=0.80; SE (63%) and SP (84%)], and A-LDL-C (AUC=0.77; SE (68%) and SP (78%)] using D-LDL-C as
gold standard. Bland–Altman plots showed a definite agreement between means and differences of D-LDL-C and the calculated
formulas with 95% of values lying within ±0.50 SD limits. The modified LDL-C (M-LDL-C) formula derived by this study yielded
a better diagnostic accuracy compared to A-LDL-C and F-LDL-C equations and thus could serve as a substitute for D-LDL-C and
F-LDL-C equations in the Ghanaian population.
1. Background
Cardiovascular diseases (CVDs) are the leading cause of
morbidity and mortality globally [1, 2]. High LDL-C is of
longstanding clinical and research interest as it is an indepen-
dent risk factor for cardiovascular events and coronary heart
diseases (CHDs) [3, 4]. The advent of lipoprotein cholesterol
measurement led to epidemiologic analyses that considered
the potential effects of the various particles on cardiovascular
(CVD) risk [5]. Previous studies have clearly incriminated
high levels of LDL-C as atherogenic and have established a
link between elevated LDL-C and cardiovascular events [6, 7].
Since the inception of Friedewald’s LDL-C equation in
1972, it has been used most widely to estimate LDL-C in
clinical practice as well as in health screenings [8]. The
American National Cholesterol Education Program (NCEP)
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working group on lipoprotein measurements recommended
that LDL-C concentration be determined with a total ana-
lytical error not exceeding ±12% (≤4% imprecision and ≤4%
inaccuracy) to guarantee correct patient classification into
NCEP risk categories [8].However there have been numerous
attempts to improve its accuracy and reliability in population-
based studies [9–12]. Regardless of the importance of accurate
evaluation for LDL-C, the Friedewald’s formula with its
inherent remarkable deviation and limitation continues to
be used in clinical and research settings as a cost-effective
method to estimate LDL-C when triglyceride levels are less
than 4.52 mmol/l [13].
Ultracentrifugation and beta-quantitation are the gold
standards for LDL-C measurement [14]. Other methods
include direct measurement of LDL-C using a homogenous
assay. These methods are expensive, inconvenient, and not
readily available in most routine laboratories. Not only is
ultracentrifugation as a separation method tedious and time-
consuming, but high salt concentrations and centrifugal
forces can substantially alter high labile lipoproteins [15, 16].
Furthermore, the diagnostic performance of direct measure-
ment of LDL-C is limited by high triglycerides (TG) levels
[17]. In addition, the concentrations of TGs in the various
lipoprotein fractions are known to be heterogeneous and
therefore change with lipid disorders and other conditions
[17, 18].
Previous studies have shown that the formula underrates
LDL-C and CV risk stratification even when triglyceride
levels are below 4.52 mmol/l [13, 19]. Following the afore-
mentioned drawbacks, Anandaraja et al. and Vojovic et al.
have attempted to derive formulas that are specific for Indian
and Serbian population, respectively [11, 20]. Martin et al.
also provided an alternative to improve LDL-C estimation
in a South African population but proposed that external
validation and further modifications were needed to improve
its utilization [9].
The heterogeneity of population, as well as differences
in dietary habits, calls for a more population-specific LDL-
C formula that will be generic, accurate, and precise. The
scarcity of literature on modified LDL-C formula in a West
African population makes it necessary that we begin to
document and validate existing formulas in our setting.
Research in this direction will provide the breakthrough in
combating the burden of atherosclerosis and serve as a useful
guide for stakeholders in the management and control of
cardiovascular diseases in Ghana. Using fasting lipid profile
data from patients who visited the laboratory department
of the National Cardiothoracic Centre, this study validated
the existing LDL-C formulas and derived a modified LDL-C
formula specific to a Ghanaian population.
2. Materials and Methods
2.1. Study Design/Site. This was a comparative study for the
estimation of LDL-Cusing three different formulas and direct
estimation by a homogenous assay. Data was collected for
the lipid profile samples received in the laboratory unit of
the National Cardiothoracic Centre (NCC) in Accra from
December 2016 to April 2017. The NCC in Korle Bu, Accra,
is one of the few functioning referral centres in West Africa
where complete evaluation of cardiothoracic diseases is not
only possible but very safe and of a standard comparable
internationally.
2.2. Ethical Consideration. This study was approved by the
Committee on Human Research, Publication and Ethics
(CHRPE) of School of Medical Sciences, KNUST. The sub-
jects were adequately informed of the purpose, procedures,
nature, risks, and minimal discomfort of the study. Partici-
pants were coded and assured of strict anonymity, confiden-
tiality, and the freedom to exit or decline participation at any
time without penalty.
2.3. Sample Size and Selection of Participants. Samples for
lipid profile analysis were collected from patients visiting
the laboratory unit of the NCC over the period stated. This
was after participants had given their consent. Of a total of
1540 samples analysed, 22 were excluded because they had
triglyceride levels greater than 4.52mmol/l (400mg/dl). The
sample size of 1518 (N=1518) was comprised of 782 males and
736 females.
2.4. Inclusion and Exclusion Criteria. Participants with no
evidence of metabolic conditions (diabetes, chronic renal
failure) as per clinical history and had observed at least ten
(10) hours of overnight fasting were included. Samples with
triglyceride levels greater than 4.52mmol/l (400mg/dl) were
excluded.
2.5. Sample Collection and Biochemical Assays. A volume of
at least 3 mL of venous blood was taken into plain tubes
after a 12-hour or minimum of 8-hour overnight fast via
phlebotomy. The blood could clot, and serum was separated
by centrifugation (2000g for 10mins) and analysed on URIT
8210 automatic chemistry analyser by TC and TG were
measured enzymatically by CHOD-PAP and Glycerol phos-
phate peroxidase-PAP methods, respectively, using reagent
kit obtained from Human Diagnostic Worldwide, Germany.
TC andTGwere calibrated using general chemistry calibrator
provided by Human Diagnostic. The reagent kit for direct
LDL-C assay, the Chema LDL direct FL test, was manufac-
tured by Hospitex Diagnostics, Italy. HDL-c measurement
was performed using a direct homogenous method without
precipitation with the use of enzymatic colorimetric assay
provided by Human Diagnostic, Germany. LDL-C concen-
tration was directly determined by enzymatic assays.
LDL-C concentrations were also calculated by Friede-
wald’s, Anandaraja’s and Martin’s formula as follows:
F-LDL-C = TC – HDL – (TG/5)
A-LDL-C = (0.9TC) – (0.9XTG/5) – 28
N-LDL-C = TC – HDL-C – TG/Novel Factor (all
calculated in mg/dL).
2.6. Derivation of M-LDL-c in a Ghanaian Population. Re-
examination of Friedewald’s formula for LDL-C determi-
nation in our setting is based on the current results, fol-
lowing the procedure which led to Friedewald’s formula
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derivation. Factor for VLDL-C concentration estimation
was recalculated. Total cholesterol, TG, LD-C, and HDL-C
concentration measurements were used in the initial group
to calculate the VLDL-C/TG ratio for a Ghanaian population.
The sum of HDL-C and LDL-C was subtracted from TC for
each person. This accounted for the assessment of VLDL-
C concentration for each person. Afterwards, to determine
the mean of the ratio, the TG concentration was divided by
the corresponding calculated VLDL-C. The mean ratio, TG/
VLDL, was 4 compared to 2.2 according to Friedewald, M-
LDL-C (mmol/L) =TC-HDL-C-TG/4.0 [11]
2.7. Data Analysis. Data collected were stored in MS Excel
spread sheet. Using the Statistical Package for Social Sciences
program (SPSS, version 21.0 for Windows) and GraphPad
prism (Version 5 for windows, Inc. 2007), statistical analyses
were carried out. Results are expressed as means ± SD and
percentages in parenthesis. Unpaired t-test and one-way
ANOVA were used to compare mean values of continuous
variables for two and more than two categories. Person’s
correlation analysis was used to determine the association
between directly measured LDL-C and calculated LDL-
C. The Bland-Altman plots for comparison were used to
determine level of bias and agreement of the calculated LDL-
C to direct LDL-C. Linear regression analysis was used to
generate linear models for the estimation of LDL-C. For
all statistical comparisons, a P < 0.05 was considered as
statistically significant.
3. Results
Lipoprotein concentrations and their distributions in the
validation group are given in Table 1. The D-LDL-C values
were significantly lower than F-LDL-C, ALDL-C, N-ALDL-
C, andM-ALDL-C values (p < 0.001).Themean absolute bias
amongst calculated LDL-Cs compared to the direct method
was 0.29 ± 0.34 mmol/L for Friedewald’s formula, 0.27 ±
0.33 mmol/L for Martin’s formula, 0.57 ± 0.31 mmol/L for
Anandaraja’s formula, and 0.50 ± 0.34 mmol/L for modified
formula.
Themean %ΔLDL between calculated LDL-Cs compared
to the direct method was 12.39 ± 27.34% for Friedewald’s
formula, 11.74 ± 29.25% for Martin’s formula, 23.54 ± 30.45%
for Anandaraja’s formula, and 21.33± 28.43% for modified
formula (Table 2).
The ability of the formulas to correctly classify subjects
at the clinical decision cut-off points in specific subgroups is
shown in Table 3. Separate analysis was done for subgroups
defined by cut-off values (ranges) for TC, TG, and D-LDL-
C values provided by NCEP ATPIII guidelines. There were
significantly lowermean values of F LDLC in the first quartile
of TC compared to D-LDLC and higher mean values in the
rest of the quartiles for TC, and few ranges of TG and of
LDL-C. A-LDL-C were significantly higher (p < 0.001) than
most ranges of TC in the D-LDL-C. A-LDL-C showed no
significant difference compared to D-LDL-C in TG and LDL-
C. N-LDL-C was significantly lower in the first range of TC
in the D-LDL-C but significantly higher in the rest of the
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Figure 1: ROC curves depicting the accuracy of the different forms
of LDL-C measurements.
significant difference compared to D-LDL-C in TG and LDL-
C except 3.10±0.93 and 2.31±0.65, respectively (p < 0.001). M-
LDL-C was significantly higher (p < 0.001) compared to D-
LDLC in all ranges of TC and in most ranges of TG and of
LDL-C (Table 3).
From Table 4, a cut-off value of 2.92 mmol/L F-LDL-C
had a sensitivity of 0.63 and specificity of 0.84 with negative
predictive value of 0.87 and positive predictive 0.74. With N-
LDL-C, cut-off value 2.92 was used; this yielded a sensitivity
of 0.63 and specificity of 0.85 for detection of LDL-C with
positive predictive value of 0.78 and negative predictive value
of 0.87. A-LDL-Chad sensitivity of 0.68 and specificity of 0.73.
M-LDL-C had a sensitivity of 0.60 and specificity of 0.88 with
a cut-off value of 3.23mmol/L.
Figure 1 shows receiver operating characteristics (ROC)
curve analyses for depicting the accuracy of Friedewald’s
formula (F-LDL-C),Martin’s formula (N-LDL-C), andAnan-
daraja’s formula (A-LDL-C) and M-LDL-C, LDL-C calcu-
lated bymodified formula. Area under curve (AUC) was 0.80
for F-LDL-C, 0.81 for N-LDL-C, 0.77 for A-LDL-C, and 0.81
for M-LDL-C.
Correlation analysis between various formulas is used
to estimate the LDL-C concentrations. With respect to
the Pearson correlation coefficient (r) and coefficient of
determination (R2), various formulas were strongly positive
correlated with each other (p<0.0001) (Table 5).
Figure 2 shows Bland-Altman plots for direct LDL-C
against Friedewald’s formula (F-LDL-C), Martin’s formula
(N-LDL-C), and Anandaraja’s formula (A-LDL-C) and M-
LDL-C, LDL-C calculated by modified formula. The mean















































































































































































































































































































































































































Journal of Lipids 5
Table 2: Mean percentage difference between D-LDL-C and calculated LDL-C.
 F-LDL-C (%) N-LDL-C (%) A-LDL (%) M-LDL-C (%)
Mean 12.39 11.74 23.54 21.33
SD 27.34 29.25 30.45 28.43
1st Quartile 4.33 5.07 1.39 3.63
Median 13.79 13.51 23.84 23.8
3rd Quartile 29.63 28.55 44.81 39.11
SD: standard deviation; ΔA-LDL-C: mean percentage difference for Friedwald’s formula; ΔA-LDL-C: mean percentage difference for Martin formula; ΔA-
LDL-C: mean percentage difference for Anandaraja’s formula; ΔA-LDL-C: mean percentage difference for modified formula. Mean percentage difference was
calculated as [(calculated LDL-C)-(D-LDL-C)] D-LDL-C∗100].
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Figure 2: Bland and Altman plot of the different forms of LDL-C measurements (F-LDL-C, N-LDL-C, A-LDL-C, and M-LDL-C).
bias for F-LDL-C was 0.28(0.24-0.32), 0.27(0.23-90.31) for
N-LDL-C, 0.52(0.48-0.56) for A-LDL-C, and 0.49(0.45-0.53)
for M-LDL-C.
4. Discussion
Currently, the NCEP guidelines focus on diagnosis and treat-
ment of TC and LDL-C. It is therefore relevant to accurately
estimate LDL-C, as it has significant implications on car-
diovascular risk stratification and can affect therapy and
outcomes. The gold standard methods for quantifying LDL-
borne cholesterol in serum are laborious and thus poorly
suited to the modern laboratory [21]. Furthermore, many
kinds of equipment and tubes are used, making conditions
difficult to reproduce from one laboratory to another and
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Table 4: Diagnosis performances of the various formulas.
Formulas Cut-off point AUC 95% CI Sensitivity (95% CI) Specificity (95%CI) NPV PPV
F-LDL-C 2.92 0.80 0.78-.83 0.63(0.60-0.67) 0.84(0.82-0.87) 0.87 0.74
N-LDL-C 2.92 0.81 0.78-.83 0.63(0.60-0.66) 0.85(0.82-0.87) 0.87 0.78
A-LDL-C 2.96 0.77 .75-.78 0.68(0.65-0.72) 0.73(0.70-0.77) 0.68 0.73
M-LDL-C 3.23 0.81 .78-.83 0.60(0.56-0.64) 0.88(0.85-0.90) 0.72 0.72
AUC: area under curve; CI: confidence interval; NPV: negative predictive value; PPV: positive predictive value; FLDL-C, LDL-C calculated by Friedewald’s
formula; N-LDL-C, LDL-C calculated by Martin’s formula; A-LDL-C, LDL-C calculated by Anandaraja’s formula; M-LDL-C, LDL-C calculated by modified
formula.
Table 5: Pearson correlation coefficient (r) (bold) and coefficient of determination (R2) (italics) between formulas.
Formulas F-LDL N-LDL A-LDL M-LDL D-LDL-C
F-LDL-C (mmol/L) 0.995 0.947 0.994 0.693
<0.0001 <0.0001 <0.0001 <0.0001
N-LDL-C (mmol/L) 0.991 0.937 0.999 0.693
<0.0001 <0.0001 <0.0001 <0.0001
A-LDL-C (mmol/L) 0.898 0.878 0.935 0.658
<0.0001 <0.0001 <0.0001 <0.0001
M-LDL-C (mmol/L) 0.989 0.999 0.8743 0.693
<0.0001 <0.0001 <0.0001 <0.0001
D-LDL-C (mmol/L) 0.481 0.480 0.434 0.481
<0.0001 <0.0001 <0.0001 <0.0001
FLDL-C, LDL-C calculated by Friedewald’s formula; N-LDL-C, LDL-C calculated by Martin’s formula; A-LDL-C, LDL-C calculated by Anandaraja’s formula;
M-LDL-C, LDL-C calculated by modified formula.
consistent separations highly dependent on the skills and
care of the technician [16]. Nevertheless, ultracentrifugation
remains the classic comparison method and is the basis
for the accepted reference methods [16, 17, 21]. Numerous
studies have been conducted to derive more precise formulas
for LDL-C calculations in the past decades in different
populations compared to the globally used Friedewald’s
formula [11, 20–22]. However, some of these modifications
were not found to be suitable replacements of the Friedewald
formula.This present study sought to compare the diagnostic
performances of the Friedewald’s (F-LDL-C), Martin’s (N-
LDL-C), and Anandaraja’s (A-LDL-C) formulas to directly
measured LDL-C in the Ghanaian population and to derive
possible predictive equation for calculating LDL-C among
our study population.
Lipoprotein concentrations and their distributions were
analyzed in this study and we found significant differences
between the mean values of F-LDL-C, N-LDL-C, A-LDL-C,
and M-LDL-C with respect to D-LDL-C mean values. M-
LDL-C values were significantly higher compared to the rest
of the formulas except A-LDL-C (Table 1). This finding is not
agreement with reports from a study conducted by Vujovic
et al. in a Serbian population [11]. According to their work,
mean LDL-C of participants directly measured was higher
than those of calculated formulas; they reported a percentage
difference of -6.9% for F-LDL-C and -3.9% of A-LDL-C
[11]. We found a mean percentage differences of 12.39% and
23.54% for F-LDL-C and A-LDL-C, respectively (Table 2). In
addition, Gupta and colleagues also found measured LDL-C
to be higher than that obtained with the calculated formulas
[23]. On the other side, Boshtam et al. found that mean
levels of D-LDL-C were lower than F-LDL-C in Iranian
population [24] which is consistent with results in this study.
Our results showed that mean difference between the two
methods was statistically significant (P<0.0001). In parallel,
some studies have demonstrated similar trend with higher
results with calculated LDL-C for F-LDL-C as compared to
directly measured LDL-C [25, 26].
Reports from the original study for the development of
Friedewald’s formula provided a simple division of blood
plasma TG by 5 for mg/dL or 2.2 for mmol/L [22]; however
this formula does not provide accurate estimation of VLDL-
C. In our course to evaluate the reliability of Friedewald’s,
Martin’s, and Anandaraja’s formula, we developed a new
modified formula, which closely resembles Friedewald’s that
exhibited a simple division of patient’s plasma TG by 4. Sev-
eral studies have suggested alterative calculation in different
populations which include TG/2.2, TG/2.5. TG/2.8, TG/3.0,
TG/3.3, and TG/3.9 (mmol/L) [27, 28].
The difference between calculated LDL-C and directly
measured LDL-C results can be important regarding risk
classification for coronary heart disease among patients [29].
In 2008, a study done by Jun et al., among Koreans, showed
that F-LDL-C was significantly different from D-LDL-C over
the concentration ranges of both TC and TG. In the same
study, the mean %ΔLDL was -9.1% and it was anticipated that
this difference was critical for the evaluation of patients with
hyperlipidemia [30]. In this study, mean values of F-LDL-C
were lower than that of D-LDL-C in the first quartile of TC
with a mean %ΔLDL-C of -5.0%. However, F-LDL-C values
8 Journal of Lipids
were higher compared to the directly measured LDL-C in
the rest of the quartiles for TC and few ranges of TG and
LDL-C (Table 3). Of note, LDL-C levels calculated with our
modified formula (M-LDL-C) were statistically significantly
higher compared to D-LDL-C in all ranges of TC and inmost
ranges of TC and that of LDL-C to correctly classify subjects
at the clinical decision cut-off points in specific subgroups.
F-LDL-C had a sensitivity of 63.0% and specificity of
84.0% with negative predictive value of 87.0% and positive
predictive 74.0% with a cut-off of 2.92 mmol/L in this study.
M-LDL-C had a sensitivity of 0.60 and specificity of 0.88 with
a cut-off value of 3.23mmol/L. These findings contrast with
reports from a study by Martin et al. in South Africa. In their
work, they recorded a higher sensitivity and specificity with
a cut-off of 2.5 mmol/L [9]. The possible reason for these
inconsistencies might be that F-LDL-c is poor in assessing
direct LDL-C when the LDL-C values are high and the
different study populations in the studies [31].
In general, there were strong correlations among the vari-
ous formulas for estimating LDL-C concentrations. However,
moderate correlations were observed between the directly
measured LDL-C and the various methods. Among the
three formulas used in this study, the Anandaraja’s formula
showed the least correlation with the directly measured LDL-
C (Table 5). The observed correlations are lower compared
with reports from previous studies [25, 32–34]. These studies
reported correlations of 0.88 [25] and 0.86 [33] and 0.786 [32],
respectively. Another study conducted among Japanese also
found a positive correlation between F-LDL-C and D-LDL-C
[34]. Furthermore, Anandaraja and colleagues also reported
a Pearson’s correlation coefficient of 0.97 between LDL-C
measured by their formula and D-LDL-C which was better
as compared to that for F-LDL-C [20]. Conversely, Kapoor et
al. found a lower correlation between A-LDL-C and D-LDL-
C which is in relative agreement with the lower correlation
coefficient of 0.658 observed in this present study [35].
Bland-Altman graphs showed a clear relationship
between both the directly measured LDL-C and the
calculation formulas. The observed low bias can be well
appreciated in all plots though the bias between N-LDL-
C and D-LDL-C was the lowest. This indicates that the
calculation formulas and the directly measured LDL-
C methods are systematically producing similar results
(Figure 2). Some previous studies have reported that
Friedewald calculation demonstrates better agreement with
directly measured LDL-C [23, 36].
This study has strength being the first study to compare
different methods of estimating LDL-c concentration in
Ghana and theWest African subregion.However, our study is
limited by the fact that both derived models must be further
scrutinized and validated bearing in mind the differences
in race and the specific character of the applied method of
measurement.
5. Conclusion
The modified LDL-c (M-LDL-c) formula derived by this
study yielded a better diagnostic accuracy compared to
A-LDL-c and F-LDL-c equation and thus could serve as
a substitute for D-LDL-c and F-LDL-c equation in the
Ghanaian population. Taking into consideration the racial
variances as well as the specific character of the applied
method of measurement, the study findings underscore the
need for scrutiny, validation, and reliability evaluations of the
generatedmodels, to ascertain their clinical use. Furtherwork
should also examine the performance of rick calculations by
the various formulae.
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